Description

Drug Classification:

Iron Hydroxy Polymaltose Complex with Folic Acid Tablets belong to the class of drugs known as iron supplements. This combination product combines the benefits of iron supplementation with the essential nutrient folic acid, offering a comprehensive approach to addressing iron deficiency anemia and supporting maternal health during pregnancy.

Formulations:

• Iron Hydroxy Polymaltose Complex with Folic Acid Tablets:
  • Strength: Each tablet contains 100 mg of Iron (as Iron Hydroxy Polymaltose Complex) and 0.35mg of Folic Acid.
  • Product Form: Oral tablets for convenient and precise dosing.
  • Packing Specs: Available in packs of 20 tablets.

Indications:

Iron Hydroxy Polymaltose Complex with Folic Acid Tablets are indicated for the prevention and treatment of iron deficiency anemia, particularly in individuals with inadequate dietary intake, increased iron requirements (such as during pregnancy or lactation), or conditions associated with impaired iron absorption or utilization. Additionally, the inclusion of folic acid provides supplemental support for maternal health and fetal development during pregnancy.

Usage:

• Iron Hydroxy Polymaltose Complex with Folic Acid Tablets should be taken orally with water, preferably with or immediately after meals to enhance absorption and minimize gastrointestinal side effects.
• For the prevention and treatment of iron deficiency anemia, the recommended dosage is typically one tablet daily or as directed by a healthcare provider.
• Pregnant women or individuals with increased iron requirements may require higher doses, as determined by their healthcare provider based on individual needs and clinical assessment.

Dosage:

• The recommended dosage of Iron Hydroxy Polymaltose Complex with Folic Acid Tablets is one tablet daily.
• Dosage adjustments may be made based on individual iron and folic acid requirements, as determined by a healthcare provider.

Pharmacokinetics:

• Iron Hydroxy Polymaltose Complex is a well-absorbed form of iron that offers high bioavailability and minimal gastrointestinal side effects compared to traditional iron salts.
• Folic Acid is readily absorbed from the gastrointestinal tract and undergoes hepatic metabolism, with the majority of absorbed folic acid being converted into its active form, methyltetrahydrofolate.

Pharmacodynamics:

• Iron Hydroxy Polymaltose Complex with Folic Acid Tablets replenish iron stores and support hemoglobin synthesis, thereby correcting iron deficiency anemia and improving red blood cell production.
• Folic Acid supplementation helps prevent neural tube defects and supports maternal health during pregnancy by promoting DNA synthesis and cellular growth.

Side Effects:

• Common side effects associated with Iron Hydroxy Polymaltose Complex with Folic Acid Tablets may include gastrointestinal disturbances such as nausea, constipation, or diarrhea.
• Iron supplementation may rarely cause allergic reactions or iron overload in susceptible individuals, particularly with prolonged or excessive use.
• Folic Acid supplementation is generally well-tolerated but may mask vitamin B12 deficiency symptoms in certain individuals.

Trust in the efficacy and safety of Iron Hydroxy Polymaltose Complex with Folic Acid Tablets from AIT Pharmaceuticals Division. Whether you are seeking to address iron deficiency anemia or support maternal health during pregnancy, our product offers a comprehensive solution backed by scientific research and pharmaceutical expertise. For more information, please visit our website or consult your healthcare provider.